Literature DB >> 3885769

Toxic heme in sickle cells: an explanation for death of malaria parasites.

A U Orjih, R Chevli, C D Fitch.   

Abstract

In an effort to elucidate a mechanism of genetic resistance to malaria, we asked whether a toxic form of heme is included in the excess of ferriprotoporphyrin IX (FP) which has been reported to accumulate as hemichromes in sickle cells. When FP is bound to certain erythrocytic elements, such as native hemoglobin, it is inaccessible to bind chloroquine with high affinity and is nontoxic. However, when FP is accessible to bind chloroquine with high affinity, it has been demonstrated to be sufficiently free to have membrane toxicity and, under certain conditions, to lyse Plasmodium falciparum parasites. [14C]-chloroquine was used, therefore, as a reporter molecule to evaluate the quantity, accessibility, and potential toxicity of FP released from hemoglobin. Intact erythrocytes from subjects with sickle cell anemia bound approximately 71 mumoles of chloroquine per kg with an apparent Kd of 10(-6) M. Erythrocytes from normal subjects or subjects with sickle trait bound little or no chloroquine with high affinity. Since the oxidant stress introduced by malaria parasites would increase the tendency for denaturation of hemoglobin S with additional release of FP, we suggest that FP toxicity accounts for the death of malaria parasites in sickle cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3885769     DOI: 10.4269/ajtmh.1985.34.223

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Sickle cell anemia with malaria: a rare case report.

Authors:  Narendra Kumar Gupta; Meenakshi Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-21       Impact factor: 0.900

Review 2.  Oxidative stress in malaria; implications for prevention and therapy.

Authors:  N S Postma; E C Mommers; W M Eling; J Zuidema
Journal:  Pharm World Sci       Date:  1996-08

3.  Myocyte injury by hemin.

Authors:  V Bhoite-Solomon; G Kessler-Icekson; N Shaklai
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-08       Impact factor: 2.416

4.  Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals.

Authors:  Y A Abu-Zeid; T G Theander; N H Abdulhadi; L Hviid; B O Saeed; S Jepsen; J B Jensen; R A Bayoumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

5.  Sickle cell disease and malaria.

Authors:  S H Arif
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

6.  Increased accumulation of chloroquine and desethylchloroquine in homozygous sickle cells.

Authors:  A U Orjih
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

7.  Significance of higher drug concentration in erythrocytes of mice infected with Schistosoma japonicum and treated orally with mefloquine at single doses.

Authors:  Yi Tao; Jian Xue; Bin Jiang; Hao-Bing Zhang; Shu-Hua Xiao
Journal:  Parasitol Res       Date:  2015-09-04       Impact factor: 2.289

8.  Design, synthesis and bioactivities of phenithionate analogues or derivatives for anti-schistosomiasis.

Authors:  Shiyang Zhou; Gangliang Huang
Journal:  Medchemcomm       Date:  2017-12-22       Impact factor: 3.597

Review 9.  Biochemical and immunological mechanisms by which sickle cell trait protects against malaria.

Authors:  Lauren Gong; Sunil Parikh; Philip J Rosenthal; Bryan Greenhouse
Journal:  Malar J       Date:  2013-09-11       Impact factor: 2.979

10.  Antiplasmodial Cyclodecapeptides from Tyrothricin Share a Target with Chloroquine.

Authors:  Adrienne N-N Leussa; Marina Rautenbach
Journal:  Antibiotics (Basel)       Date:  2022-06-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.